Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/01/2005WO2004066949A3 Antisense oligonucleotides that inhibit expression of hif-1
12/01/2005WO2004059556A3 Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein
12/01/2005WO2004043394A3 Modulation of huntingtin interacting protein 1 expression
12/01/2005WO2004005482A3 Methods and compositions for the production, identification and purification of fusion proteins
12/01/2005WO2003049703A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/01/2005WO2003027632A3 Use of isogenic human cancer cells for high-throughput screening and drug discovery
12/01/2005WO2002092012A3 Compositions and methods for treating tumors bearing hmfg and cea antigens
12/01/2005US20050268359 Plant centromere compositions
12/01/2005US20050268358 Plants having improved growth characteristics and a method for making the same
12/01/2005US20050268357 Method for producing direct in vitro flowering and viable seed from cotyledon, radicle, and leaf explants, and plants produced therefrom
12/01/2005US20050268356 Modification of plant metabolism
12/01/2005US20050268355 Modified threonine deaminase
12/01/2005US20050268354 Nucleic acid molecules encoding cyclotide polypeptides and methods of use
12/01/2005US20050268353 Insect viruses and their uses in protecting plants
12/01/2005US20050268352 Materials and methods for the alteration of enzyme and acetyl CoA levels in plants
12/01/2005US20050268351 Modulation of storage organs
12/01/2005US20050268350 Identification and purification of higher order transcription complexes from transgenic non-human animals
12/01/2005US20050268349 Transgenic mice containing brain-specific membrane-anchored protein gene disruptions
12/01/2005US20050268348 Mouse model for psoriasis and psoriatic arthritis
12/01/2005US20050267299 Polynucleotide, transcription and translational initiation codon context of given sequence; transforming plant protoplast
12/01/2005US20050267297 Nucleotide sequences coding zinc metalloprotease for identifying modulators for treatment of infection; drug screening; pharmacogenomic
12/01/2005US20050267295 Method for selective removal of a substance from samples containing compounds having nucleic acid structure
12/01/2005US20050267294 Antibodies with increased affinities for anthrax antigens
12/01/2005US20050267065 Modulation of Aurora B expression
12/01/2005US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization
12/01/2005US20050267063 Antisense modulation of p70 S6 kinase expression
12/01/2005US20050267062 Endothelial growth factors; antiischemic agents; neovascularization
12/01/2005US20050267061 Methods and compositions for treating neuropathic and neurodegenerative conditions
12/01/2005US20050267060 Combinatorial methods and compositions for treatment of melanoma
12/01/2005US20050267059 Syk-targeted nucleic acid interference
12/01/2005US20050267058 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sINA)
12/01/2005US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides
12/01/2005US20050267053 Use of macrolides in pest control
12/01/2005US20050267036 Peptide sequence derived from the C-terminus of CaV2.2. and inhibits the interaction of CaV2.2 with Mint1-PDZ1, a glutathione S transferase fusion protein; neurotransmitter-release angonists of CaV2.2, the pore-forming subunit of N-type of voltage-dependent calcium channels; antinocciceptive agents
12/01/2005US20050267024 Polypeptide, cancer therapy, neovascularization defects, retinopathies, arthritis and psoraisis
12/01/2005US20050267022 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
12/01/2005US20050267020 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
12/01/2005US20050266569 Regulator/promoter for tunable gene expression and metabolite sensing
12/01/2005US20050266568 Molecule-releasing apparatus and molecule-releasing medhod
12/01/2005US20050266567 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
12/01/2005US20050266566 Viral vector in which gene for Sendai viral protein selected from NP, P, and L proteins is deleted or inactivated while all other gene functions are retained; use as expression vector in e.g. gene therapy; efficient system for reconstituting Sendai virus
12/01/2005US20050266565 Expression vector for use as gene delivery tool in transfer of exogenous genes into hematopoietic stem cells; improving heterologus gene expression
12/01/2005US20050266564 Tetracycline-regulated gene expression in HSV-1 vectors
12/01/2005US20050266563 Methods and compositions relating to neuronal cell and tissue differentiation
12/01/2005US20050266561 Use of interfering RNA in the production of transgenic animals
12/01/2005US20050266560 Plant chromosome compositions and methods
12/01/2005US20050266559 Shade responsive promoter, promoter control elements, and combinations, and uses thereof
12/01/2005US20050266558 Compositions isolated from forage grasses and methods for their use
12/01/2005US20050266552 Reagents and methods for identification of RNAi pathway genes and chemical modulators of RNAi
12/01/2005US20050266550 TC-83-derived alphavirus vectors, particles and methods
12/01/2005US20050266549 Molecular switch for regulating mammalian gene expression
12/01/2005US20050266544 Methods and compositions for increasing viral vector production in packaging cell lines
12/01/2005US20050266541 Methods and compositions for evolving microbial hydrogen production
12/01/2005US20050266534 Nucleotide sequences which code for the cstA gene
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266528 Proteolytic blood coagulation factor for treatment and prevention of preclampsia and thrombotic disorders
12/01/2005US20050266527 Human G-protein receptor HIBEF51
12/01/2005US20050266525 Expression control sequence
12/01/2005US20050266524 Beta integrin gene and protein
12/01/2005US20050266523 Glycorandomization and the production of novel erythronolide and coumarin analogs
12/01/2005US20050266522 Human amine receptor
12/01/2005US20050266519 Methods and compositions for modulating and detecting activin dimer and dimer formation
12/01/2005US20050266518 Comprises sequences coding hydroxymethylglutaryl-CoA reductase (HMG-COA reductase), isopentenyl diphosphate isomerase (IDI), mevalonate kinase, hydroxymethylglutaryl-CoA synthase (HMG-CoA synthase) for biosynthesis of zeaxanthin
12/01/2005US20050266517 Transformant containing transaldolase gene
12/01/2005US20050266502 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/01/2005US20050266498 Method for screening biomolecule activity regulator
12/01/2005US20050266488 Adjust efficiency translation of polypeptides; gene expression; vaccine; isolated Dna
12/01/2005US20050266486 Methods for treating obesity by inhibiting expression of obese gene product receptor variant
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266484 gene therapy; a sequence which encodes the polypeptide podocin; proteinuria
12/01/2005US20050266483 Novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
12/01/2005US20050266482 Regulation of human CYSLT2-like GPCR protein
12/01/2005US20050266480 Nucleotide sequences coding for interleukin polypeptide for use as tool in tissue repair
12/01/2005US20050266479 Cloning, expression and characterization of the SPG4 gene responsible for the most common form of autosomal dominant spastic paraplegia
12/01/2005US20050266475 Method for determining an analyte
12/01/2005US20050266472 Apparatus and method for detecting bio molecule using inductance device
12/01/2005US20050266470 25501, a human transferase family member and uses therefor
12/01/2005US20050266464 C1q family member proteins with altered immunogenicity
12/01/2005US20050266463 introducing into plant cell comprising gene of interest a polynucleotide encoding human PMS2-134 or Arabidopsis PMS2-134 proteins, where polynucleotide has termination codon at codon 134 or after codons 1-147, which when expressed forms truncated PMS2 protein, cell becomes hypermutable, testing cell
12/01/2005US20050266462 Magnetic glass particles, method for their preparation and uses thereof
12/01/2005US20050266461 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/01/2005US20050266457 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms
12/01/2005US20050266453 Mutagenesis methods using ribavirin and/or RNA replicases
12/01/2005US20050266452 Novel human kinases and polynucleotides encoding the same
12/01/2005US20050266451 Obtaining antibodies with desired characteristics by isolating complementary determining regions DNA sequences and incorporating them into scaffold; shuffling polynucleotide sequences
12/01/2005US20050266448 Method of nucleic acid analysis, nucleic acid analysis device and disk for nucleic acid analysis
12/01/2005US20050266447 Method for identifying activators of gene transcription
12/01/2005US20050266445 Purified mammalian CTLA-8 antigens and related reagents
12/01/2005US20050266444 Generating genomic patterning array for preferential cellular tissues; gene and genome mapping
12/01/2005US20050266441 Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
12/01/2005US20050266440 genetic engineered plants, whose cells are transfected with recombinant nucleic acid molecules that code a polyketide synthases for the production of polyunsaturated fatty acids (PUFAs); trangenic plants
12/01/2005US20050266439 Thermostable RNA ligase from thermus phage
12/01/2005US20050266436 thermostable mutants of B-type DNA polymerases comprising a Y-GG/A amino acid motif between the N-terminal 3'-5'-exonuclease domain and the C-terminal polymerase domain whereas the tyrosine of the Y-GG/A amino acid motif is mutated and whereas these mutant DNA polymerases are suitable for PCR.
12/01/2005US20050266435 VR1 receptors and uses thereof
12/01/2005US20050266434 Biosynthetic gene cluster for ambruticins
12/01/2005US20050266430 A mutated G-CSF mRNA or cDNA fragment having a deletion of an exon 3 region for use; primer for use in amplification of a G-CSF gene
12/01/2005US20050266426 Confluence regulated adhesion molecules useful in modulating vascular permeability
12/01/2005US20050266425 Methods for producing and identifying multispecific antibodies
12/01/2005US20050266424 Real-time sequence determination
1 ... 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 ... 4023